000 | 01890 a2200541 4500 | ||
---|---|---|---|
005 | 20250517133455.0 | ||
264 | 0 | _c20170619 | |
008 | 201706s 0 0 eng d | ||
022 | _a0946-1965 | ||
024 | 7 |
_a10.5414/CP202842 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFujimoto, Mai | |
245 | 0 | 0 |
_aAngiotensin receptor blockers and the risk of cancer: data mining of a spontaneous reporting database and a claims database
. _h[electronic resource] |
260 |
_bInternational journal of clinical pharmacology and therapeutics _cApr 2017 |
||
300 |
_a295-303 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministrative Claims, Healthcare |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAdverse Drug Reaction Reporting Systems |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xadverse effects |
650 | 0 | 4 |
_aBreast Neoplasms _xepidemiology |
650 | 0 | 4 | _aData Mining |
650 | 0 | 4 | _aDatabases, Factual |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aJapan _xepidemiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms _xchemically induced |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 |
_aPancreatic Neoplasms _xchemically induced |
650 | 0 | 4 |
_aProstatic Neoplasms _xchemically induced |
650 | 0 | 4 | _aProtective Factors |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aUnited States _xepidemiology |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aKanou, Migiwa | |
700 | 1 | _aHosomi, Kouichi | |
700 | 1 | _aTakada, Mitsutaka | |
773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 55 _gno. 4 _gp. 295-303 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.5414/CP202842 _zAvailable from publisher's website |
999 |
_c26776935 _d26776935 |